@Innameonly....DXB announced successful completion of phase 3 trials, then TH for a CR in March.
You can't compare a registration and approval of a new drug, which in lay man terms is commercialisation, with completion of phase 3 trials, which in lay man terms means apply for the registration of a new drug and go through the 12 month assessment period.
Peas and carrots.
Fact is IMHO, nobody can predict what will happen if successful approval arrives this week. If it doesn't then we all know the adverse impact on the SP.
BOT - Anything but charting, page-8832
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.025(7.46%) |
Mkt cap ! $567.0M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 33.3¢ | $14.94M | 42.66M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 112268 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 276101 | 7 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |